Trials / Completed
CompletedNCT06691906
A Clinical Study of Enlicitide Decanoate (MK-0616) in Healthy Adult Participants (MK-0616-025)
A Clinical Study to Evaluate the Relative Bioavailability of MK-0616 Formulations in Healthy Adult Participants
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- All
- Age
- 19 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to learn what happens to the amount of enlicitide decanoate in the blood when enlicitide decanoate is given in different formulations.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Enlicitide decanoate | Oral tablet |
Timeline
- Start date
- 2024-03-18
- Primary completion
- 2024-05-01
- Completion
- 2024-05-01
- First posted
- 2024-11-18
- Last updated
- 2024-11-18
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06691906. Inclusion in this directory is not an endorsement.